About this trial
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing hip fracture repair aged 18-85.
Disqualifiers
Patients who have an exclusion to regional anesthesia.
Patients who are pregnant assessed via self-report or pregnancy test if they have taken one.
Non-English speakers
Patients who already had their fracture repaired"
Trial design
Parallel
Treatments tested in this trial
PENG block and cryoablation
Drugwill receive an ultrasound guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves.
fascia iliaca compartment block
Drugwill receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour
Treatment groups
Trial outcomes
Primary outcomes
Maximum pain score on Post-operative day 30
Maximum pain score on day 30 post surgery. Pain Scale is 0-10 with 0 meaning no pain (better outcome) and 10 meaning worst pain imaginable (worse outcome).
Opioid use
Opioid use and Functional Pain scores on POD 0, 1, 2, 3, 4, 5, 6, 7 - measured in milligrams morphine equivalents
functional pain scores
Functional Pain Score on Post Operative Day 0, 1, 2, 3, 4, 5, 6, 7 - measured with Pain Scale 0-10 with 0 meaning no pain (better outcome) and 10 meaning worst pain imaginable (worse outcome)
number of patients using opioids
measured in number of patients
Sponsors and contacts
Click on the lead sponsor to view all of their trials.